Since there are very few if any guidelines in the clinical research industry when it comes to social media study participant recruitment, I decided to make this video offering some practical advice on how I would handle certain scenarios. Always check with your own Institutional Review Board to be on the safe side.
In this video, I answer a viewer's question on what separates an adverse event from a serious adverse event and when a Principal Investigator needs to report either in a clinical trial.
Social media is certainly creating an altogether new category for regulatory and IRB oversight. In this video I give my personal opinion of when utilizing tools like social media require IRB oversight. Let me know your thoughts.
I received a unique question from a viewer that touched upon numerous issues that might be of importance to some other audience members. The first would be the difference between academic and industry funded clinical trials. Another issue would be mergers and acquisitions amongst research sites. Finally, a great amount of explanation into fundamental clinical research site operations was discussed. I hope you find value here.
In this video, I give a bird's eye macro view on the entire clinical trial process from the perspective of a clinical research site. I have noticed that I often get into topics with such great detail that the bigger picture is often difficult to observe. This video attempts to do just that, zoom all the way out so we can all have a better understanding and context that can make studying the nuances of this industry that much easier.